Discover
JAZZ
Jazz Pharmaceuticals plc
237.51
2 x 219.14
2 x 258.46
bid
ask
-
3.46
1.44%
2 @ 04:00 PM
237.40 -0.11 (0.05%)
| Ytd | 39.71% | |
| 1y | 117.02% |
234.87
day range
241.50
105.00
52 week range
243.32
| Open | 240.47 | Prev Close | 240.97 | Low | 234.87 | High | 241.50 | Mkt Cap | 14.92B |
| Vol | 819.63K | Avg Vol | 945.61K | EPS | 0.12 | P/E | 1979.25 | Forward P/E | 9.41 |
| Beta | 0.33 | Short Ratio | 4.30 | Inst. Own | 108.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 225.59 | 200-d Avg | 179.19 | 1yr Est | 257.00 |
| Income Statement | |||
| Total Revenue | 1.07B | ||
| Revenues (USD) | 1.07B | ||
| Cost of Revenue | 134.10M | ||
| Gross Profit | 934.80M | ||
| Operating Expenses | 598.20M | ||
| Research and Development Expense | 196.00M | ||
| Selling, General and Administrative Expense | 352.70M | ||
| Operating Income | 336.60M | ||
| Interest Expense | 39.90M | ||
| Income Tax Expense | 6.10M | ||
| Net Income | 293.10M | ||
| Net Income Common Stock | 293.10M | ||
| Net Income Common Stock (USD) | 293.10M | ||
| Consolidated Income | 293.10M | ||
| Earnings per Basic Share | 4.73 | ||
| Earnings per Basic Share (USD) | 4.73 | ||
| Earnings per Diluted Share | 4.43 | ||
| Earning Before Interest & Taxes (EBIT) | 339.10M | ||
| Earning Before Interest & Taxes (USD) | 339.10M | ||
| Weighted Average Shares | 61.90M | ||
| Weighted Average Shares Diluted | 66.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.84B | ||
| Cash and Equivalents (USD) | 1.84B | ||
| Investments | 1.03B | ||
| Investments Current | 1.03B | ||
| Trade and Non-Trade Receivables | 836.30M | ||
| Current Assets | 4.58B | ||
| Property, Plant & Equipment Net | 258.90M | ||
| Total Assets | 11.86B | ||
| Debt Current | 1.03B | ||
| Total Debt | 5.40B | ||
| Current Liabilities | 2.25B | ||
| Debt Non-Current | 4.37B | ||
| Total Liabilities | 7.33B | ||
| Accumulated Retained Earnings (Deficit) | 939.20M | ||
| Accumulated Other Comprehensive Income | -651.00M | ||
| Shareholders Equity | 4.53B | ||
| Shareholders Equity (USD) | 4.53B | ||
| Assets Non-Current | 7.28B | ||
| Total Debt (USD) | 5.40B | ||
| Goodwill and Intangible Assets | 6.01B | ||
| Inventory | 437.50M | ||
| Liabilities Non-Current | 5.08B | ||
| Trade and Non-Trade Payables | 100.00M | ||
| Tax Assets | 907.00M | ||
| Tax Liabilities | 641.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 181.40M | ||
| Net Cash Flow from Financing | -78.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 452.40M | ||
| Capital Expenditure | -19.70M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 122.80M | ||
| Issuance (Purchase) of Equity Shares | -103.60M | ||
| Issuance (Repayment) of Debt Securities | -7.80M | ||
| Net Cash Flow from Investing | 123.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 20.00M | ||
| Net Cash Flow from Operations | 408.20M | ||
| Effect of Exchange Rate Changes on Cash | -400.00K | ||
| Share Based Compensation | 74.50M | ||